Highlights from ASCO 2025 in early-stage NSCLC include updates on CheckMate 816 on neoadjuvant nivolumab, NeoADAURA on osimertinib, and data on low-dose CT screening, presented by Dr Jonathan Goldman.

The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...

Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no ...

Initiating intensive blood pressure lowering soon after ICH is linked to better outcomes compared to currently recommended ...

The European agency has started a review of sodium oxybate to assess its use to treat alcohol withdrawal syndrome and support ...

Dupilumab has been approved by the FDA for the treatment bullous pemphigoid in adults, the manufacturer Regeneron announced.

The EMA has extended the indications for Darzalex (daratumumab) to the treatment of adults at high risk of developing ...

Switching from diet sodas to water may help women with type 2 diabetes and obesity or overweight lose more weight and improve ...

Many established medical therapies to treat myasthenia gravis remain in use, and newer options are available for patients who ...

For suspected axial spondyloarthritis, preliminary data from a study suggested MRI or CT of the sacroiliac joints were better ...

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

In the context of new anti-obesity medications, the American College of Cardiology has issued a Scientific Statement updating ...